Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
Systane Eye Drops Recall Issued Due to Risk Single-Use Vials May Be Contaminated Fungal contamination of Systane “On-the-Go” eye drops may cause users of the single vials to experience severe eye irritation and a potential risk of vision loss. December 26, 2024 Michael Adams Add Your Comments Alcon Laboratories has issued a voluntary recall for Systane Lubricant Eye Drops Ultra PF, which were sold in single-use “On-the-Go” vials, due to potential fungal contamination that could expose users to a risk of severe health consequences, including eye irritation and potential vision loss. Systane Lubricant Eye Drops are marketed for the temporary relief of burning eye irritation symptoms caused by having dry eyes, with the fluid contained in single-use plastic vials with a tip that can be torn off. The U.S. Food and Drug Administration (FDA) announced the eye drop recall on December 23, indicating that at least one lot of the Systane “On-the-Go” Eye Drops may be contaminated by a fungus, which could lead to eye infections and vision loss for some users, or death for those who are immunocompromised. Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Alcon first became aware of the issue after a customer complained about foreign matter that was observed in a vial of Systane Eye Drops. A company investigation determined that the contaminant was fungal in nature, and could lead to severe adverse health consequences if used. As a result, the manufacturer issued a voluntary recall of one lot of the product on December 21. At the time, no injuries or deaths had been reported as a result of the recalled product. The affected Systane Eye Drops is limited to lot number 10101, with an expiration date of 2025/09. The eye drops are sold in a green and pink carton, which contains 25 single-use LDPE vials of sterile solution each. The brand names “Systane” and “Ultra PF” appear on the front of the carton, as well as the package size of “25 vials.” Distributors will be notified by letter, email or phone, and are eligible for a replacement of any recalled products. Customers who are still in possession of the affected lot of Systane Eye Drops should immediately stop using them and return the package to the place of purchase for a refund or replacement. Those who experience adverse reactions should contact their healthcare providers immediately. Questions regarding the recall can be directed to Alcon Laboratories, which can be reached at 1-800-241-5999 between 7:30 a.m. and 6:00 p.m. (CT), Monday to Friday. Customers can also report any illnesses or quality problems to the FDA’s MedWatch Adverse Event Reporting program online, or by downloading the appropriate form and returning it by fax to 1-800-FDA-0178 or by regular mail to the address on the form. Tags: Eye Drops, Eye Drops Recall, Fungal, Fungal Contamination, Fungal Infection, Fungus, Systane, Systane Eye Drops Image Credit: FDA More Lawsuit Stories BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker March 5, 2025 Antibiotic Resistant Bacteria Found on Nursing Home Residents’ Skin: Study March 5, 2025 Ford Electric Mustangs Could Trap Occupants With Electronic Doors, Lawsuit Claims March 5, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (Posted: today) A group of eight lawyers have been recommended to serve in various leadership positions in the Biozorb litigation, taking actions that benefit all plaintiffs pursuing cases over injuries caused by the recalled breast tissue marker. MORE ABOUT: BIOZORB LAWSUITSchedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)Joint BioZorb Marker Lawsuit Claims Implant Caused Seroma, Infections and Other Complications (02/04/2025) Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (Posted: yesterday) A hair relaxer wrongful death lawsuit blames 16 years of using popular hair relaxer products like Just for Me and Dark & Lovely for the development of a fatal case of endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program (02/03/2025) Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (Posted: 2 days ago) Judge is calling for Depo-Provera lawyers to submit applications for MDL leadership by the end of the week, indicating that female attorneys should be adequately represented. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Judge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)Depo-Provera Lawyers Will Meet With MDL Judge For Initial Case Management Conference on Friday (02/18/2025)
BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker March 5, 2025
BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (Posted: today) A group of eight lawyers have been recommended to serve in various leadership positions in the Biozorb litigation, taking actions that benefit all plaintiffs pursuing cases over injuries caused by the recalled breast tissue marker. MORE ABOUT: BIOZORB LAWSUITSchedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)Joint BioZorb Marker Lawsuit Claims Implant Caused Seroma, Infections and Other Complications (02/04/2025)
Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (Posted: yesterday) A hair relaxer wrongful death lawsuit blames 16 years of using popular hair relaxer products like Just for Me and Dark & Lovely for the development of a fatal case of endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program (02/03/2025)
Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (Posted: 2 days ago) Judge is calling for Depo-Provera lawyers to submit applications for MDL leadership by the end of the week, indicating that female attorneys should be adequately represented. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Judge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)Depo-Provera Lawyers Will Meet With MDL Judge For Initial Case Management Conference on Friday (02/18/2025)